Teleflex Incorporated

TFX: NYSE
40Total

Lowest reading is at 22 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Jason Weidman

Market Cap

5.17 Billion USD

Sector

Healthcare

Website

https://www.teleflex.com

Last Update

27/09/2026, 17:49:17

Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Read More

Strongest readings

  • ✔Cashflow and earnings growth is strong (growth score 62 out of 100)
  • ✔Share count has been falling at 0.39% per year
  • ✔Debt is low at 0.97 times equity

Weakest readings

  • ✘The current price sits above estimated fair value (margin of safety -43.85%)

Key Figures

StatusMetricValueReadingMarket avg
Price / earnings (TTM)
N/A19.60x
✘
Margin of safety (DCF)
-43.85%
17.95%
✘
Revenue growth (5y average)
1.61%
10.97%
✘
Dividend yield (TTM)
1.16%
1.85%
✔
Share count, per year
-0.39%
0.00%
✘Return on capital employed1.20%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

36 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
Price / earnings
N/A19.60x
✘Free cashflow yield3.26%
4.70%
Price / earnings growthN/A1.50x
Price / book1.78x
—
✘
Margin of safety
-43.85%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 68.55 USD is below the current price of 122.07 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 87.8 USD ✘

Current Price: 122.1 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

62 / 100

Growing faster than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
1.61%
10.97%
✔Earnings growth28.19%
14.48%
✔Cashflow growth17.04%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (30.70% against a five year average of 1.61%)
  • ✔Free cashflow growth has improved this year

Health

42 / 100

Balance sheet is stretched on several measures.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✘Altman-Z score1.79
3.00
✔Piotroski score7.00
5.00
✘Debt / equity0.97x
0.80x
✔Current ratio2.60x
1.00x
✔Interest coverage2.61x
2.50x
✘Free cashflow / debt0.03x
0.15x
✔Debt / capital0.49x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Dividend

    52 / 100

    Covered, with limited headroom.

    StatusMetricValueReadingMarket avg
    ✘
    Dividend yield
    1.16%
    1.85%
    ✘Dividend growth-1.79%
    0.00%
    ✔Payout ratio (earnings)-5.80%
    40.00%
    ✔Payout ratio (cashflow)35.56%
    65.00%
    ✔Worst year, last 5 years-1.79%
    -2.00%

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Dividend growth has been slowing recently

    Management

    22 / 100

    Returns on capital are below the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity3.43%
    15.00%
    ✘Return on capital employed1.20%
    10.00%
    Return on assets1.47%
    —
    Free cashflow return on capital1.28%
    —
    ✘Return on capital, 5y change-0.51%
    0.00%
    ✔
    Share count, per year
    -0.39%
    0.00%
    ✔Share count, recent-2.73%
    0.00%
    ✘Realized buyback return-41.59%
    0.00%
    ✘Goodwill erosion / equity45.92%
    2.00%
    Price volatility, 5 year35.00%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Shares were repurchased while the value score was only 36 out of 100

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    TFX

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Teleflex Incorporated

    Currency

    USD

    Beta

    0.814

    Vol Avg

    606517

    Ceo

    Mr. Jason Weidman

    Cik

    0000096943

    Cusip

    Exchange

    NYSE

    Full Time Employees

    15500

    Industry

    Medical Instruments & Supplies

    Sector

    Healthcare

    Ipo Date

    Address

    550 East Swedesford Road

    City

    Wayne

    State

    PA

    Country

    United States

    Zip

    19087-1603

    Phone

    610-225-6800

    Analysis Last Updated

    27/09/2026, 17:49:17

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies